Cite

HARVARD Citation

    Nazarian, J. et al. (n.d.). DIPG-49. International preclinical drug discovery and biomarker program informing an adoptive combinatorial trial for DMG. Neuro-oncology. pp. i29-i30. [Online]. 
  
Back to record